(4) unfavorable: MLL-PTD and/or RUNX1 mutation and/or ASXL1 mutation (n = 203.     ///    "One thousand patients with cytogenetic data were investigated for the following molecular alterations: PML-RARA, RUNX1-RUNX1T1, CBFB-MYH11, FLT3-ITD, and MLL-PTD, as well as mutations in NPM1, CEPBA, RUNX1, ASXL1, and TP53. "